LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Pollock, A.; Hazelton, C.; Henderson, C.A.; Angilley, J.; Dhillon, B.; Langhorne, P.; Livingstone, K.; Munro, F.A.; Orr, H.; Rowe, F.J.; Shahani, U. (2011)
Publisher: Cochrane Collaboration, by John Wiley and Sons Ltd.
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: genetic structures
Background Eye movement disorders may affect over 70% of stroke patients. These eye movement disorders can result in difficulty maintaining the normal ocular position and difficulty moving the eyes appropriately. The resulting functional disabilities include a loss of depth perception, reduced hand-to-eye co-ordination, marked difficulties with near tasks and reading and reduced ability to scan the visual environment. They can also impact on the effectiveness of rehabilitation therapy. There are a wide variety of different treatment interventions proposed for eye movement disorders after stroke. However, in the past, there has been a lack of evidence specific to the impact of interventions on the functional outcome of patients with stroke. Objectives To determine the effects of interventions for eye movement disorders on functional ability following stroke. Search strategy We searched the Cochrane Stroke Group Trials Register (February 2011), the Cochrane Eyes and Vision Group Trials Register (December 2009) and nine electronic bibliographic databases including CENTRAL (The Cochrane Library 2009, Issue 4), MEDLINE (1950 to December 2009), EMBASE (1980 to December 2009), CINAHL (1982 to December 2009), AMED (1985 to December 2009), and PsycINFO (1967 to December 2009). We also searched reference lists and trials registers, handsearched journals and conference proceedings, and contacted experts. Selection criteria Randomised trials in adults after stroke where the intervention was specifically targeted at improving the eye movement disorder or improving the ability of the participant to cope with the eye movement disorder. The primary outcome was functional ability in activities of daily living. Secondary outcomes included functional ability in extended activities of daily living, eye movement measures, balance, falls, depression or anxiety, discharge destination or residence after stroke, quality of life and social isolation, adverse events, and death. Data collection and analysis Two authors independently screened abstracts, extracted data and appraised trials. We undertook assessment of methodological quality for allocation concealment, blinding of outcome assessor, method of dealing with missing data, and other potential sources of bias. Main results Two studies ( 28 participants but only five were people with stroke) met the inclusion criteria and were included in this review. Both studies investigated pharmacological interventions for disorders of eye movement in patients with stroke. It was not appropriate to pool data and we were not able to draw conclusions from these studies. We found no other randomised studies which investigated interventions for disorders of eye movement in patients with stroke. Authors' conclusions There is insufficient evidence to reach conclusions about the effectiveness of interventions for patients with eye movement disorders after stroke. High quality research in the form of well-designed randomised trials are urgently required.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Mathias 1986 Mathias S, Nayak U, Isaacs B. Balance in elderly patients: the “Get-up and Go” test. Archives of Physical Medicine and Rehabilitation 1986;67:387-9.
    • Pederson 1981 Pederson RA, Troost BT. Abnormalities of gaze in cerebrovascular disease. Stroke 1981;12(2):251-4.
    • RevMan 2011 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
    • Riggs 2007 Riggs RV, Andrews K, Roberts P, Gilewski M. Visual deficit interventions in adult stroke and brain injury. American Journal of Physical Medicine and Rehabilitation 2007;86: 853-60.
    • Rowe 2009a Rowe F, Brand D, Jackson CA, Price A, Walker L, Harrison S, et al.Visual impairment following stroke: do stroke patients require vision assessment?. Age and Ageing 2009; 38:188-93.
    • Rowe 2009b Rowe F, VIS Group. The profile of strabismus in stroke survivors. Eye 2010; Vol. 24, issue 4:682-5. [DOI: 10.1038/eye.2009.138] Rowe 2009c Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006499.pub2] Smith 1990 Smith P, Hamilton BB, Granger CV. The fone FIM. Buffalo, New York: Research Foundation of the State University of New York, 1990.
    • Tinetti 1990 Tinetti ME, Richman D, Powell L. Falls efficacy as a measure of falling. Journal of Gerontology 1990;45(6): 239-43.
    • Wolter 2006 Wolter M, Preda S. Visual deficits following stroke: maximising participation in rehabilitation. Topics in Stroke Rehabilitation 2006;13(3):12-21.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article